Laxative disease: a modern look at the problem


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article deals with the problem of laxative disease that often develops against the background of irrational treatment of chronic constipation, as well as the abuse of laxatives. The pathogenesis of this pathology is discussed; current diagnostic and therapeutic approaches are provided.

Full Text

Restricted Access

About the authors

A. A Samsonov

FSBEI HE MSMSU n.a. A.I. Evdokimov of RMH

E. V Partsvaniya-Vinogradova

FSBEI HE MSMSU n.a. A.I. Evdokimov of RMH

D. N Andreev

FSBEI HE MSMSU n.a. A.I. Evdokimov of RMH

Email: dna-mit8@mail.ru
PhD, Teaching Assistant at the Department of Propedeutics of Internal Diseases and Gastroenterology

A. V Maruscha

FBHCI “Chief Clinical Hospital" of Ministry of Internal Affairs of Russia

References

  1. Leung L., Riutta T., Kotecha J., Rosser W. Chronic constipation: an evidence-based review. J. Am. Board Fam. Med. 2011;24(4):436-51.
  2. Mugie S.M., Benninga M.A., Di Lorenzo C. Epidemiology of constipation in children and adults: a systematic review. Best Pract. Res. Clin. Gastroenterol. 2011;25(1):3-18.
  3. Руководство по внутренней медицине / Под ред. Г.П. Арутюнова, А.И. Мартынова, А.А. Спасского. М., 2015.
  4. Kurniawan I., Simadibrata M. Management of chronic constipation in the elderly. Acta Med. Indones. 2011;43(3):195-205.
  5. Маев И.В., Самсонов А.А., Дичева Д.Т., Андреев Д.Н. Обстипационный синдром. Мед. вестн. МВД. 2012;LIX(4):42-5.
  6. Цветкова Л.Н. Профилактика и лечение запоров у детей. Вопр. соврем. педиатрии. 2004;3(5):2-7.
  7. Auth M.K., Vora R., Farrelly P., Baillie C. Childhood constipation. BMJ. 2012;345:e7309.
  8. Higgins P.D.R, Johanson J.F.J. Epidemiology of constipation in North America: a systematic review. Am. J. Gastroenterol. 2004;99:750-59.
  9. Walter S., Hallbook O., Gotthard R., Bergmark M., Sjodahl R. A population-based study on bowel habits in a Swedish community: prevalence of faecal incontinence and constipation. Scand. J. Gastroenterol. 2002;37:911-16.
  10. Dennison C., Prasad M., Lloyd A., Bhattacharyya S.K., Dhawan R., Coyne K. The health-related quality of life and economic burden of constipation. Pharmacoeconomics. 2005;23:461-76.
  11. Маев И., Андреев Д., Дичева Д., Гуртовенко И. Риск длительного применения слабительных препаратов. Врач. 2014;1:26-30.
  12. Creytens G. Le Lactulose dans le traitement de la constipation chronique et labus des laxatives. Ars média. 1980;35:737-57.
  13. Roerig J.L., Steffen K.J., Mitchell J.E., Zunker C. Laxative abuse: epidemiology, diagnosis and management. Drugs. 2010;70(12):1487-503.
  14. Tozzi F., Thornton L.M., Mitchell J.E., et al., on behalf of the Price Foundation Collaborative Group. Features associated with laxative abuse in individuals with eating disorders. Psychosom. Med. 2006;68:470-77.
  15. Vanin J.R., Saylor K.E. Laxative abuse: a hazardous habit for weight control. J. Am. Coll. Health. 1989;37:227-30.
  16. Pomeroy C., Mitchell J.E., Roerig J., et al. Medical complications of psychiatric illness. Washington, DC: Am. Psychiatric Publishing, Inc. 2002. P. 35-74.
  17. Baker E.H., Sandle G.I. Complications of laxative abuse. Ann. Rev. Med. 1996;47:127-34.
  18. Marquart L.F., Sobal J. Weight loss beliefs, practices and support systems for high school wrestlers. J. Adolesc. Health. 1994;15:410-15.
  19. Shelton J.H., Santa Ana C.A., Thompson D.R., Emmett M., Fordtran J.S. Factitious diarrhea induced by stimulant laxatives: accuracy of diagnosis by a clinical reference laboratory using thin layer chromatography. Clin. Chem. 2007;53:85-90.
  20. Keswani R.J., Sauk J., Kane S.V. Factitious diarrhea masquerading as refractory celiac disease. South Med. J. 2006;99:293-95.
  21. Neims D.M., McNeill J., Giles T.R., Todd F. Incidence of laxative abuse in community and bulimic populations: a descriptive review. Int. J. Eat. Disord. 1995;17:211-28.
  22. Steffen K.J., Mitchell J.E., Roerig J.L. The eating disorders medicine cabinet revisited: a clinician's guide to ipecac and laxatives. Int. J. Eat. Disord. 2007;40:360-68.
  23. Kokot F., Hyla-Klekot L. Drug-induced abnormalities of potassium metabolism. Pol. Arch. Med. Wewn. 2008;118(7-8):431-34.
  24. Wald A. Is chronic use of stimulant laxatives harmful to the colon? J. Clin. Gastroenterol. 2003;36:386-89.
  25. Wright L.F., DuVal Jr.J.W. Renal injury associated with laxative abuse. South Med. J. 1987;80:1304-306.
  26. Vanderperren B., Rizzo M., Angenot L., Haufroid V., Jadoul M., Hantson P. Acute liver failure with renal impairment related to the abuse of senna anthraquinone glycosides. Ann. Pharmacother. 2005;39:1353-57.
  27. Slugg P.H., Carey W.D. Clinical features and follow-up of surreptitious laxative users. Cleveland Clin. Q. 1984;51:167-71.
  28. Urso F.P., Urso M.J., Lae C.H. The cathartic colon: pathological findings and radiological/ pathological correlation. Radiology. 1975; 116(3):557-59.
  29. Campbell W.L. Cathartic colon. Reversibility of roentgen changes. Dis. Colon. Rectum. 1983;26(7):445-48.
  30. Freeman H.J. Melanosis in the small and large intestine. World J. Gastroenterol. 2008;14(27):4296-99.
  31. Kostela E., Kulju T., Collan Y. Melanosis coli, prevalence, distribution and histological features in 200 consecutiveautopsies at Kuopio University Central Hospital. Dis. Colon. Rectum. 1989;32(3):235-39.
  32. Ahasan H.N., Khan A.I., Mahbub H., et al. Melanosis Coli - An Atypical Presentation. J. Med. 2010;11(2):183-85.
  33. Walker N.I., Bennett R.E., Axelsen R.A.: Melanosis coli. A consequence of anthraquinone induced apoptosis of colonic epithelial cells. Am. J. Pathol. 1988;131(3):465-66.
  34. Müller-Lissner S. The pathophysiology, diagnosis, and treatment of constipation. Dtsch. Arztebl. Int. 2009;106(25):424-31.
  35. Harris A., Buchanan G.N. Melanosis coli is reversible. Colorectal. Dis. 2009;11:788-89.
  36. Greenfeld D., Mickley D., Quinlan D.M., Roloff P. Hypokalemia in outpatients with eating disorders. Am. J. Psychiatry. 1995;152:60-3.
  37. Duncan A. Screening for surreptitious laxative abuse. Ann. Clin. Biochem. 2000;37:1-8.
  38. Phillips S., Donaldson L., Geisler K., Pera A., Kochar R. Stool composition in factitial diarrhea: a 6-year experience with stool analysis. Ann. Intern. Med. 1995;123(2):97-100.
  39. Lacy B.E., Mearin F., Chang L., et al. Bowel Disorders. Gastroenterology. 2016;150: 1393-407.
  40. Wald A. Chronic constipation: advances in management. Neurogastroenterol Motil. 2007;19(1):4-10.
  41. Маев И., Дичева Д., Андреев Д. Новые возможности в лечении хронического запора. Врач. 2012;3:45-8.
  42. Маев И.В., Самсонов А.А., Андреев Д.Н. Современный алгоритм ведения пациентов с синдромом хронического запора с позиций внедрения новых фармакологических препаратов. Фарматека. 2012;13:37-43.
  43. Rao S.S. Constipation: evaluation and treatment. Gastroenterol. Clin. North. Am. 2003;32: 659-83.
  44. Pare P. The approach to diagnosis and treatment of chronic constipation: suggestions for a general practitioner. Can. J. Gastroenterol. 2011;25(Suppl. B):36-40.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies